Hong Kong-based Leaders Group eyes stake in Dr Datsons

The Hong Kong-based funding institution Leaders Group Asia Limited hasreportedly shown interest in buying a majority stake in bulk drug manufacturer Dr Datsons Labs Ltd. The company has received aletter of intent from Leaders Group Asia Limited for investment in Dr Datsons, said the company in a BSE filing on December 15, 2014.
 
DrDatsons Labs is an research based pharmaceutical company and manufactures and supplies a wide variety of bulk drugs & generic formulations to both domestic & export markets.
 
Leaders Group Asia Limited,which has investments and business interests in varied segments, intends to invest in Dr Datsons subject to due diligence and other approvals as it aligns with its interests and supplies of products to many countries in Africa and South America, added the BSE filing.
 
DrRajendraKamat (chairman, Dr Datsons) and Dr KannanVishwanath (managing director, Dr Datsons) are expected to meet the management of Leaders Group Asia Limited in Hong Kong for finalising the terms and conditions and magnitude of investment.
 
To take the deal forward, Dr Datsons is planning to demerger of the company into bulk drugs and formulations entities.